產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
- 400-999-210024小時(shí)服務(wù)熱線
MDA-MB-453 (人乳腺癌細(xì)胞) (STR鑒定正確)
貨號:CL-0152
規(guī)格:1×10?cells/T25培養(yǎng)瓶
價(jià)格: ¥1800
生長培養(yǎng)基:Leibovitz's L-15+10% FBS+1% P/S
推薦搭配
套餐1:
細(xì)胞培養(yǎng)最優(yōu)解!
套餐組合價(jià):¥2150¥2350
搭配套餐已成功加入購物車!
套餐2:
細(xì)胞培養(yǎng)最優(yōu)解!
套餐組合價(jià):¥2150¥2250
搭配套餐已成功加入購物車!
產(chǎn)品概述
名稱 | MDA-MB-453 (人乳腺癌細(xì)胞) (STR鑒定正確) |
別稱 | MDA-MB 453; MDA MB 453; MDA-MB453; MDAMB453; MDA-453; MDA453; MD Anderson-Metastatic Breast-453 |
種屬 | 人類 |
生長特性 | 半貼半懸 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
生長培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,100%, 溫度:37℃
|
培養(yǎng)方案B(可選) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:4 |
推薦換液頻率 | 2-3次/周 |
注意事項(xiàng) | 1.該細(xì)胞推薦使用Leibovitz's L-15培養(yǎng)基進(jìn)行培養(yǎng),Leibovitz's L-15不可以通入二氧化碳,會(huì)產(chǎn)生細(xì)胞毒性;2.如您沒有無二氧化碳的培養(yǎng)箱,可使用DMEM替代Leibovitz's L-15,使用DMEM培養(yǎng)基時(shí)即可正常通入5%二氧化碳;3.配套專用培養(yǎng)基默認(rèn)Leibovitz's L-15配置,如需DMEM配方,請聯(lián)系銷售下單備注更改。 |
背景描述 | MDA-MB-453細(xì)胞是由R·Cailleau等在1976年從一位48歲女性腫瘤轉(zhuǎn)移患者胸水中建立的細(xì)胞株,其它轉(zhuǎn)移灶包括淋巴結(jié)、腦和胸水及心包腔積水;MDA-MB-453細(xì)胞過表達(dá)FGF受體。 |
年齡(性別) | 女性,48歲 |
組織來源 | 乳腺;源自轉(zhuǎn)移部位:胸腔積液 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 乳腺癌細(xì)胞 |
生物安全等級 | BSL-1 |
倍增時(shí)間 | ~26-38 hours |
致瘤性 | No, in immunosuppressed mice.Yes, in semisolid medium. |
受體表達(dá)情況 | fibroblast growth factor (FGF), expressed |
保藏機(jī)構(gòu) | ATCC; HTB-131 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 10,12 D2S1338 23,24 D3S1358 15 D5S818 11 D7S820 10 D8S1179 10,12 D13S317 12 D16S539 9 D18S51 15,20 D19S433 13,14 D21S11 29,31 FGA 18,23 PentaD 9,10 PentaE 11 TH01 6 TPOX 10 vWA 17,18 D6S1043 11,18 D12S391 18,21 D2S441 10 -
STR鑒定圖
參考文獻(xiàn)
-
Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer(2021/04/19)
作者:Xinxing Wang, Bingjian Xue, Yujie Zhang
期刊:Cell Death & Disease
DOI:10.1038/s41419-021-03684-x
影響因子 :9.000
引用產(chǎn)品:CL-0040 CL-0041 CL-0149 CL-0150 CL-0152 CL-0290 CL-0525
-
CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis(2021/07/19)
作者:Mingzhi Zhu, Yanyan Wang, Fang Wang
期刊:Cancer Cell International
DOI:10.1186/s12935-021-02088-3
影響因子 :5.800
-
A Novel Optical Fiber Terahertz Biosensor Based on Anti-Resonance for The Rapid and Nondestructive Detection of Tumor Cells(2023/10/23)
作者:Zhe He, Yueping Luo, Guorong Huang
期刊:Biosensors-Basel
影響因子 :5.400
引用產(chǎn)品:CL-0152
-
Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis | Molecular and Cellular Biology(2021/09/24)
作者:Yihong Huang, Shuo Zheng, Ying Lin, Liming Kea
期刊:Molecular And Cellular Biology
影響因子 :5.300
引用產(chǎn)品:164210 CL-0041 CL-0150 CL-0152 CL-0290 CL-0525 PB180120 PM150110 PM151010
-
Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis(2023/03/03)
作者:Yihong Huang, Shuo Zheng, Ying Lin
期刊:MOLECULAR AND CELLULAR BIOLOGY
影響因子 :5.300
引用產(chǎn)品:CL-0152
-
4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5(2022/10/05)
作者:Jing Ju, Nan Wang, Jiali Wang
期刊:Drug Design Development and Therapy
影響因子 :4.319
引用產(chǎn)品:CL-0152
-
Enantiomeric α-pyrone derivatives with immunosuppressive activity from Talaromyces adpressus(2023/11/27)
作者:Meijia Zheng, Chenxi Zhou, Hong Liao
期刊:PHYTOCHEMISTRY
DOI:10.1016/j.phytochem.2023.113931
影響因子 :3.800
引用產(chǎn)品:CL-0152
-
Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis(2023/02/06)
作者:Jiacheng Li, Xiaozhen Liu, Lin Chen
期刊:TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI:10.1016/j.taap.2023.116415
影響因子 :3.800
引用產(chǎn)品:CL-0007 CL-0093 CL-0149 CL-0150 CL-0152 CL-0290 CL-0525
-
circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/ALX4 Network(2022/10/12)
作者:Guangming Yi, Dan Wang, Jianjun Han
期刊:CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
影響因子 :3.632
引用產(chǎn)品:CL-0152
-
Sericin inhibits MDA?MB?468 cell proliferation via the PI3K/Akt pathway in triple?negative breast cancer(2020/12/13)
作者:Lin Niu, Songhe Yang, Xueying Zhao
期刊:Molecular Medicine Reports
影響因子 :3.400
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料
識別碼示意圖